|
Mutation Information
|
Mutation Site
|
V106M |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Country
|
Lesotho |
Literature Information
|
PubMed PMID
|
31781759
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
|
Title
|
Engagement in Care, Viral Suppression, Drug Resistance, and Reasons for Nonengagement After Home-Based Same-Day Antiretroviral Therapy Initiation in Lesotho: A Two-Year Follow-up of the CASCADE Trial. |
|
Author
|
Amstutz A,Brown JA,Ringera I,Muhairwe J,Lejone TI,Klimkait T,Glass TR,Labhardt ND |
|
Evidence
|
In comparison to baseline, new DRMs were detectable in both (participant CA194: V106M; participant CA336: K103N, P225H) at 24 months. The remaining 6 stated that they never started ART; in those participants, no new DRMs were detected at 24 months.
|
|
|
HIV Mutation Detail Information